Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1B Trial of Preoperative Eribulin and Radiation for Retroperitoneal Liposarcoma

NCT03361436 is registered in ClinicalTrials.gov with OHSU Knight Cancer Institute as lead sponsor.

NCT NCT03361436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03361436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1B Trial of Preoperative Eribulin and Radiation for Retroperitoneal Liposarcoma
Lead sponsor
OHSU Knight Cancer Institute
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 19, 2018
Completion date
April 14, 2033
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liposarcoma, malignant abdominal neoplasm, malignant retroperitoneal neoplasm, malignant scrotal neoplasm, malignant solid neoplasm, malignant spermatic cord neoplasm